Bio-Rad Laboratories, Inc.BIONYSE
Loading
Book Value/Share Growth AcceleratingAccelerating
Percentile Rank74
3Y CAGR-9.0%
5Y CAGR-2.0%
Year-over-Year Change
Year-over-year book value per share growth
3Y CAGR
-9.0%/yr
Quarterly compound
5Y CAGR
-2.0%/yr
Recent deceleration
Percentile
P74
Within normal range
vs 5Y Ago
0.9x
Contraction
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 10.42% |
| Q3 2025 | -4.43% |
| Q2 2025 | 9.53% |
| Q1 2025 | 1.88% |
| Q4 2024 | -12.42% |
| Q3 2024 | 12.22% |
| Q2 2024 | -24.78% |
| Q1 2024 | 4.54% |
| Q4 2023 | 4.98% |
| Q3 2023 | 0.50% |
| Q2 2023 | -12.78% |
| Q1 2023 | 1.84% |
| Q4 2022 | 13.84% |
| Q3 2022 | -4.99% |
| Q2 2022 | -11.97% |
| Q1 2022 | -25.62% |
| Q4 2021 | -11.07% |
| Q3 2021 | 32.01% |
| Q2 2021 | 9.51% |
| Q1 2021 | 7.42% |
| Q4 2020 | 11.53% |
| Q3 2020 | 19.74% |
| Q2 2020 | 17.69% |
| Q1 2020 | 9.56% |
| Q4 2019 | 11.76% |
| Q3 2019 | -6.49% |
| Q2 2019 | 12.76% |
| Q1 2019 | 21.29% |
| Q4 2018 | -18.00% |
| Q3 2018 | 5.46% |
| Q2 2018 | 3.27% |
| Q1 2018 | 53.05% |
| Q4 2017 | 2.51% |
| Q3 2017 | 1.17% |
| Q2 2017 | 3.71% |
| Q1 2017 | 4.68% |
| Q4 2016 | -4.74% |
| Q3 2016 | 3.21% |
| Q2 2016 | 2.64% |
| Q1 2016 | 2.02% |